Europe Microbiome Therapeutics Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Microbiome Therapeutics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Microbiome Therapeutics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Potential of Gut Microbiota in Maintaining Human Health
5.1.2 Inflow of Funds to Ameliorate Microbiome Discovery Pipeline

5.2 Market Opportunities

5.2.1 Increasing R&D to Gain Better Understanding of Human Microbiome

5.3 Future Trends

5.3.1 Technological Advancement in Human Microbiome Therapeutics

5.4 Impact of Drivers and Restraints

6. Europe Microbiome Therapeutics Market Regional Analysis

6.1 Europe Microbiome Therapeutics Market Overview

6.2 Europe Microbiome Therapeutics Market Revenue 2020-2030 (US$ Million)

6.3 Europe Microbiome Therapeutics Market Forecast Analysis

7. Europe Microbiome Therapeutics Market Analysis – by Type

7.1 Therapeutics and Procedure

7.1.1 Overview
7.1.2 Therapeutics and Procedure: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Microbiome Therapeutics Market Analysis – by Application

8.1 Metabolic Disorder and Obesity

8.1.1 Overview
8.1.2 Metabolic Disorder and Obesity: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

8.2 C. Difficile Infection

8.2.1 Overview
8.2.2 C. Difficile Infection: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Inflammatory Bowel Disease

8.3.1 Overview
8.3.2 Inflammatory Bowel Disease: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe Microbiome Therapeutics Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Inflammatory Bowel Disease: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Ambulatory Surgical Centers

9.2.1 Overview
9.2.2 Inflammatory Bowel Disease: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Homecare

9.3.1 Overview
9.3.2 Inflammatory Bowel Disease: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10. Europe Microbiome Therapeutics Market – Europe Analysis

10.1 Europe

10.1.1 Europe Microbiome Therapeutics Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Europe Microbiome Therapeutics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 UK: Europe Microbiome Therapeutics Market Breakdown, by Type
10.1.1.1.2 UK: Europe Microbiome Therapeutics Market Breakdown, by Application
10.1.1.1.3 UK: Europe Microbiome Therapeutics Market Breakdown, by End User

10.1.1.2 Germany: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Germany: Europe Microbiome Therapeutics Market Breakdown, by Type
10.1.1.2.2 Germany: Europe Microbiome Therapeutics Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Microbiome Therapeutics Market Breakdown, by End User

10.1.1.3 France: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 France: Europe Microbiome Therapeutics Market Breakdown, by Type
10.1.1.3.2 France: Europe Microbiome Therapeutics Market Breakdown, by Application
10.1.1.3.3 France: Europe Microbiome Therapeutics Market Breakdown, by End User

10.1.1.4 Russia: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Russia: Europe Microbiome Therapeutics Market Breakdown, by Type
10.1.1.4.2 Russia: Europe Microbiome Therapeutics Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Microbiome Therapeutics Market Breakdown, by End User

10.1.1.5 Italy: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Italy: Europe Microbiome Therapeutics Market Breakdown, by Type
10.1.1.5.2 Italy: Europe Microbiome Therapeutics Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Microbiome Therapeutics Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown, by Type
10.1.1.6.2 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Microbiome Therapeutics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Caelus Health BV

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Enterome SA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Ferring Holdings SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Vedanta Biosciences Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 YSOPIA Bioscience SA

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights